Dimorphism and pathogenesis of Histoplasma capsulatum;Dimorfismo y patogenia de Histoplasma capsulatum

Revista Argentina de Microbiologia

Volumn 38, Issue 4, 2006, Pages 235-242

  Lopez C E ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

Dimorphism; Histoplasma capsulatum; Pathogenesis

Indexed keywords

BRONCHIOLE; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONIDIUM; FUNGAL VIRULENCE; FUNGUS HYPHAE; FUNGUS TRANSMISSION; GENE EXPRESSION; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; LUNG ALVEOLUS; LUNG MYCOSIS; MACROPHAGE; MYCELIUM; NUCLEIC ACID SYNTHESIS; PATHOGENESIS; PHENOTYPIC VARIATION; REVIEW; YEAST;

BRONCHI; CALCIUM; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; HISTOPLASMA; HISTOPLASMOSIS; HUMANS; HYDROGEN-ION CONCENTRATION; IRON; LUNG; MACROPHAGES; MYCELIUM; NITRIC OXIDE; PHENOTYPE; REACTIVE OXYGEN SPECIES; REPRODUCTION, ASEXUAL; VACUOLES; VIRULENCE;

EID: 33846828582     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Abidi FE, Roth H, Keath EJ. Identification and characterization of a phase-specific, nuclear DNA binding protein from the dimorphic pathogenic fungus Histoplasma capsulatum. Infect Immun 1998; 66: 3867-73.
2. Allen HL, Deepe GS. Apoptosis modulates protective immunity to the pathogenic fungus Histoplasma capsulatum. J Clin Invest 2005; 115: 2875-85.
3. Batanghari JW, Deepe GS Jr, Cera ED, Goldman WE. Histoplasma acquisition of calcium and expression of CBP1 during intracellular parasitism. Mol Microbiol 1998; 27: 531-9.
4. Batanghari JW, Goldman WE. Calcium dependence and binding in cultures of Histoplasma capsulatum. Infect Immun 1997; 65: 5257-61.
5. Berry CL. The production of disseminated histoplasmosis in the mouse: the effects of changes in reticuloendothelial function. J Pathol 1996; 97: 441-57.
6. Bohse ML, Woods JP. Surface localization of the Yps3p protein of Histoplasma capsulatum. Eukaryot Cell 2005; 4: 685-93.
7. Carr J, Shearer G. Genome size, complexity and ploidy of the pathogenic fungus Histoplasma capsulatum. J Bacteriol 1998; 180: 6697-703.
8. Colonna-Romano S, Porta A, Franco A, Kobayashi GS, Maresca B. Identification and isolation by DDRT-PCR of genes differentially expressed by Histoplasma capsulatum during macrophages infection. Microb Pathog 1998; 25: 55-66.
9. Davies SF, Khan M, Sarosi GA. Disseminated histoplasmosis in immunologically suppressed patients. Occurrence in a nonendemic area. Am J Med 1978; 64: 94-100.
10. Deepe GS, Bullock WE. Histoplasmosis: a granulomatous inflammatory response. En: Gallin JI, Goldstein IM, Snyderman R, editors. Inflammation: Basic Principles and Clinical Correlates. New York, Raven Press, 1992, p. 943-58.
11. Deepe GS. Immune response to early and late Histoplasma capsulatum infections. Curr Opin Microbiol 2000; 3: 359-62.
12. Deepe GS. Progress in vaccination for histoplasmosis and blastomycosis: coping with cellular immunity. Med Mycol 2005; 43: 381-9.
13. Eissenberg LG, Goldman WE, Schlesinger PH. Histoplasma capsulatum modulates the acidification of phagolysosomes. J Exp Med 1993; 177: 1605-11.
14. Eissenberg LG, Goldman WE. Histoplasma variation and adaptive strategies for parasitism: new perspectives on histoplasmosis. Clin Microbiol Rev 1991; 4: 411-21.
15. Eissenberg LG, West JL, Woods JP, Goldman WE. Infection of P388D1 macrophages and respiratory epithelial cells by Histoplasma capsulatum: selection of avirulent variants and their potential role in persistent histoplasmosis. Infect Immun 1991; 9: 1639-46.
16. El-Rady J, Shearer G. Cloning and analysis of an actin-encoding cDNA from the dimorphic pathogenic fungus Histoplasma capsulatum. J Med Vet Mycol 1997; 35: 159-66.
17. El-Rady J, Shearer G. Isolation and characterization of a calmodulin-encoding cDNA from the pathogenic fungus Histoplasma capsulatum. J Med Vet Mycol 1996; 34: 163-9.
18. Feldmesser M. Histoplasma capsulatum: strategies for intracellular survival. En: Calderone RA & San Blas G, editors. Pathogenic Fungi. Host Interactions and Emerging Strategies for Control. England, Caister Academic Press, 2004, p. 72-7.
19. Gebhart D, Bahrami AK, Sil A. Identification of copper-inducible promoter for use in ectopic expression in the fungal pathogen Histoplasma capsulatum. Eukaryot Cell 2006; 5: 935-44.
20. Howard DH, Dabrowa N, Otto V, Rhodes J. Cysteine transport and sulfite reductase activity in a germination-defective mutant of Histoplasma capsulatum. J Bacteriol 1980; 141: 417-21.
21. Howell A. Studies on Histoplasma capsulatum and similar form species. 1. Morphology and development. Mycologia 1939; 31: 191-216.
22. Hung MN, Sun HY, Hsueh PR, Hung CC, Chang SC. Meningitis due to Histoplasma capsulatum and Mycobacterium tuberculosis in a returned traveler with acquired immunodeficiency syndrome. Formos Med Assoc 2005; 104: 860-3.
23. Hwang L, Hocking-Murray D, Bahrami AK, Andersson M, Rine J, Sil A. Identifying phase-specific genes in the fungal pathogen Histoplasma capsulatum using a genomic shotgun microarray. Mol Biol Cell 2003; 14: 2314-26.
24. th General Meeting of the American Society for Microbiology, 2002, Abstract F-71, p. 335, USA.
25. Johnson PC, Hamill RJ, Sarosi GA. Clinical review: progressive disseminated histoplasmosis in the AIDS patient. Semin Respir Infect 1989; 4: 139-46.
26. Kauffman CA, Israel KS, Smith JW, White AC, Schwarz J, Brooks GF. Histoplasmosis in immunosuppressed patients. Am J Med 1978; 64: 923-32.
27. Keath EJ, Abidi FE. Molecular cloning and sequence analysis of yps-3, a yeast-phase-specific gene in the dimorphic fungal pathogen Histoplasma capsulatum. Microbiology 1994; 140: 759-67.
28. Keath EJ, Painter AA, Kobayashi GS, Medoff G. Variable expression of a yeast-phase-specific gene in Histoplasma capsulatum strains differing in thermotolerance and virulence. Infect Immun 1999; 57: 1384-90.
29. Klimpel KR, Goldman WE. Cells walls from avirulent variants of Histoplasma capsulatum lack α-(1-3)-glucan. Infect Immun 1998; 56: 2997-3000.
30. Klimpel KR, Goldman WE. Isolation and characterization of spontaneous avirulent variants of Histoplasma capsulatum. Infect Immun 1987; 55: 528-33.
31. Kügler S, Sebghati TS, Eissenberg LG, Goldman WE. Phenotypic variation and intracellular parasitism by Histoplasma capsulatum. Proc Nat Acad Sci, USA, 2000; 97: 8794-8.
32. Kugler S, Young B, Miller VL, Goldman WE. Monitoring phase-specific gene expression in Histoplasma capsulatum with telomeric GFP fusion plasmids. Cell Microbiol 2000; 2: 537-47.
33. Lane TE, Wu-Hsieh BA, Howard DH. Iron limitation and the gamma interferon-mediated antihistoplasma state of murine macrophages. Infect Immunol 1991; 59: 2274-8.
34. Magrini V, Warren W, Wallis J, Goldman W, Xu J, Mardis E et al. Fosmid-based physical mapping of the Histoplasma capsulatum genome. Genome Res 2004; 14: 1603-9.
35. Maresca B, Kobayashi GS. Dimorphism in Histoplasma capsulatum and Blastomyces dermatitidis. En: Ernst, JF, Schmidt, A, editors. Dimorphism in Human Pathogenic and Apathogenic Yeasts. Contrib Microbiol Basel, Karger, 2000, p. 201-16.
36. th General Meeting of the American Society for Microbiology, 2000, Abstract F-71, p. 335, USA.
37. Medoff G, Kobayashi GS, Painter A, Travis S. Morphogenesis and pathogenicity of Histoplasma capsulatum. Infect Immun 1987; 55: 1355-8.
38. Medoff G, Sacco M, Maresca B, Painter A, Kobayashi GS. Irreversible block of the mycelial-to-phase transition of Histoplasma capsulatum. Science 1986; 231: 476-9.
39. Negroni R, Robles AM, Arechavala A, Bianchi M, Helou S. Histoplasmosis relacionada al SIDA, su estado actual en la Argentina. Prensa Médica Argentina 1997; 84: 696-700.
40. Nemecek JC, Wuthrich M, Klein BS. Global control of dimorphism and virulence in fungi. Science 2006; 312: 583-8.
41. Newman SL, Bucher C, Rhodes J, Bullock WE. Phagocytosis of Histoplasma capsulatum yeast and microconidia by human cultured macrophages. Cellular cytoskeleton requirement for attachment and ingestion. J Clin Invest 1990; 85: 223-30.
42. Newman SL, Gootee L, Brunner G, Deepe GS Jr. Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. J Clin Invest 1994; 3: 1422-9.
43. Newman SL, Gootee L, Gabay JE, Selsted ME. Identification of constituents of human neutrophil azurophil granules that mediate fungistasis against Histoplasma capsulatum. Infect Immun 2000; 68: 5668-72.
44. Newman SL, Gootee L, Kidd C, Ciraolo GM, Morris R. Activation of human macrophage fungistatic activity against Histoplasma capsulatum upon adherence to type 1 collagen matrices. J Immunol 1997; 158: 1779-86.
45. Newman SL, Gootee L, Morris R, Bullock WE. Digestion of Histoplasma capsulatum yeast by human macrophages. J Immunol 1992; 149: 574-80.
46. Newman SL, Gooteel, Bucher C, Bullock WE. Inhibition of intracellular growth of Histoplasma capsulatum yeast cells by cytokine-activated human and macrophages. Infect Immun 1991; 59: 737-41.
47. Newman SL, Gooteel. Colony stimulating factors activate human macrophages to inhibit intracellular growth of Histoplasma capsulatum yeast. Infect Human Dis 1992; 60: 4593-7.
48. Newman SL, Gootee L, Gabay JE. Human neutrophil-mediated fungistasis against Histoplasma capsulatum. Localization of fungistatic activity to the azurophil granules. J Clin Invest 1993; 92: 624-31.
49. Newman SL. Histoplasma capsulatum: diary of an intracellular survivor. En: Richard Calderone & Ronald Cihlar, editors. Fungal Pathogenesis, Principles and Clinical Applications. Basel, Marcel Dekker, Inc. 2004, p. 81-98.
50. Newman SL. Macrophages in host defense against Histoplasma capsulatum. Trends Microbiol 1999; 7: 67-71.
51. Nosanchuk JD, Gómez BL, Youngchim S, Diez S, Aisen P, Zancope-Olivera RM, et al. Histoplasma capsulatum syntesizes melanin-like pigments in vitro and during mammalian infection. Infect Immun 2002; 70: 5124-31.
52. Padenu V, Dragos, M, Radu R, Dobre V. Histoplasmosis. Pneumonologia 2005; 54: 72-5.
53. Patel JB, Batanghari JW, Goldman WE. Probing the yeast phase-specific expression of the CBP1 gene in Histoplasma capsulatum. J Bacteriol 1998; 180: 1786-92.
54. Porta A, Maresca B. Host response and Histoplasma capsulatum/ macrophage molecular interactions. Med Mycol 2000; 38: 399-406.
55. Reddy P, Gorelick DF, Brasher CA, Larsh H. Progressive disseminated histoplasmosis as seen in adults. Am J Med 1970; 48: 629-36.
56. Retallac DM, Heinecke EL, Gibbons R, Deepe GS, Woods JP. The URA5 gene is necessary for Histoplasma capsulatum growth during infection of mouse and human cells. Infect Immun 1999; 67: 624-9.
57. Retallac DM, Woods J. Molecular epidemiology, pathogenesis, and genetics of the dimorphic fungus Histoplasma capsulatum. Microbes Infect 1999; 1: 817-25.
58. Reyes-Montes MR, Bobadilla-del Valle M, Martínez-Rivera MA. Tipificación de aislados clínicos de Histoplasma capsulatum por métodos fenotípicos y genotípicos. Rev Inst Nac Enf Resp Mex 1998; 11: 195-201.
59. Reyes-Montes MR, Bobadilla-del Valle M. Relatedness analyses of Histoplasma capsulatum isolates from Mexican patients with AIDS-associated histoplasmosis by using histoplasmin electrophoretic profiles and randomly amplified polymorphic DNA patterns. J Clin Microbiol 1999; 37: 1404-8.
60. Salas-Rios MA, Reyes-Montes MR, Martínez-Rivera MA, Curriel-Quesada E, Taylos ML. Genotipificacion de cepas de Histoplasma capsulatum aisladas de pacientes con histoplasmosis asociada al SIDA, mediante el polimorfismo en la longitud de los fragmentos de restricción. Rev Ins Nac Enf Resp Mex 1998; 11: 202-7.
61. San Blas G, Niño-Vega G. Morphogenesis in other agents of systemic mycoses. En: Calderone RA & San Blas G, editors. Pathogenic Fungi. Structural Biology and Taxonomy. England, Caister Academic Press, 2004, p. 169-79.
62. Sebghati TS, Engle JT, Goldman WE. Intracellular parasitism by Histoplasma capsulatum: fungal virulence and calcium dependence. Science 2000; 290: 1368-72.
63. Sharma S, Kumari N, Ghosh P, Aggarwal A. Disseminated histoplasmosis in an immunocompetent individual. A case report. Indian J Pathol Microbiol 2005; 48: 204-6.
64. Shearer G. Cloning and analysis of cDNA encoding an elongation factor I-alpha from the dimorphic fungus Histoplasma capsulatum. Gene 1996; 161: 119-23.
65. Shearer G. Functional Genomics in Histoplasma capsulatum: dimorphism and virulence factors. En: Shaw KJ, editors. Pathogen Genomics. New Jersey, Humana Press, 2002, p. 405-21.
66. Strasser JE, Newman SL, Ciraolo GM. Regulation of the macrophage vacuolar ATPase and phagosome-lysosome fusion by Histoplasma capsulatum. J Immunol 1999; 162: 6148-54.
67. Taylor ML, Pérez-Mejía A. Yamamoto-Furusho JK, Granados J. Immunologic, genetic and social human risk factors associated to histoplasmosis: studies in the State of Guerrero, Mexico. Mycopathologia 1997; 130: 137-41.
68. Taylor ML, Reyes-Montes MR, Chávez-Tapia CB. Ecology and molecular epidemiology findings of Histoplasma capsulatum, in Mexico. Res Adv Microbiol 2000; 1: 29-35.
69. Tian, X, Shearer G. Cloning and analysis of mold-specific genes in the dimorphic fungus Histoplasma capsulatum. Gene 2001; 275: 107-14.
70. Timmerman MM, Woods JP. Ferric reduction is a potential iron acquisition mechanism for Histoplasma capsulataum. Infect Immun 1999; 67: 6403-8.
71. Weath LJ, Kauffman CA. Histoplasmosis. En: Walsh TJ, Rex JH, editors. Fungal infections. Infect Dis Clin North Am 2003; 17: 1-19.
72. Weath LJ. Histoplasma capsulatum. En: YU W, Weber R, Raoult E, editors. Antimicrobial Therapy and Vaccines. New York, Apple Trees Production, 2002, p. 1069-79.
73. Weaver CH, Sheehan KCF, Keath EJ. Localization of yeast phase-specific gene product to the cell wall in Histoplasma capsulatum. Infect Immun 1996; 64: 3048-54.
74. Wheat LJ. Histoplasmosis and coccidioidomycosis in individuals with AIDS. A clinical review. Infect Dis Clin North Am 1994; 8: 467-82.
75. Wheat LJ, Smith EJ, Sathapatayavongs B, Batteiger B, Filo RS, Leapman SB, et al. Histoplasmosis in renal allograft recipients. Two urban outbreaks. Arch Intern Med 1983; 143: 703-7.
76. Woods JP, Heinecke EL, Luecke JW, Maldonado E, Ng JZ, Retallack DM, et al. Pathogenesis of Histoplasma capsulatum. Sem Resp Infect 2001; 16: 91-101.
77. Woods JP, Retallack DM, Heinecke EL, Gibbons R, Deepe GS. Rare homologous gene targeting in Histoplasma capsulatum growth during infection of mouse and human cells. Infect Immun 1998; 67: 624-9.
78. Woods JP. Histoplasma capsulatum molecular genetics, pathogenesis, and responsiveness to its environment. Fungal Genet Biol 2002; 35: 81-97.
79. Woods JP. Knocking on the right door and making a confortable home: Histoplasma capsulatum intracellular pathogenesis. Curr Opin Microbiol 2003; 6: 327-31.
80. Zancopé-Oliveira RM, Reiss E, Lott TJ, Mayer LW, Deepe GS. Molecular cloning, characterization, and expression of the M antigen of Histoplasma capsulatum. Infect Immun 1999; 67: 1947-53.